Up to date, it has been shown that in pulmonary diseases marked by inflammatory features, a typical raise in serum CRP level takes place in response to inflammatory cytokines such as interleukin (IL)-6, IL-1 or tumoral necrosis factor (TNF)-α [22]. Here, IL6 is linked to lung disorder.